Generation and trapping of a mesoderm biased state of human pluripotency.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 10 2020
Historique:
received: 08 11 2019
accepted: 10 09 2020
entrez: 6 10 2020
pubmed: 7 10 2020
medline: 23 10 2020
Statut: epublish

Résumé

We postulate that exit from pluripotency involves intermediates that retain pluripotency while simultaneously exhibiting lineage-bias. Using a MIXL1 reporter, we explore mesoderm lineage-bias within the human pluripotent stem cell compartment. We identify a substate, which at the single cell level coexpresses pluripotent and mesodermal gene expression programmes. Functionally these cells initiate stem cell cultures and exhibit mesodermal bias in differentiation assays. By promoting mesodermal identity through manipulation of WNT signalling while preventing exit from pluripotency using lysophosphatidic acid, we 'trap' and maintain cells in a lineage-biased stem cell state through multiple passages. These cells correspond to a normal state on the differentiation trajectory, the plasticity of which is evidenced by their reacquisition of an unbiased state upon removal of differentiation cues. The use of 'cross-antagonistic' signalling to trap pluripotent stem cell intermediates with different lineage-bias may have general applicability in the efficient production of cells for regenerative medicine.

Identifiants

pubmed: 33020476
doi: 10.1038/s41467-020-18727-8
pii: 10.1038/s41467-020-18727-8
pmc: PMC7536399
doi:

Substances chimiques

Culture Media 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4989

Subventions

Organisme : Medical Research Council
ID : MR/R015724/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L012537/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L012650/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 12796
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N000838/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U137973817
Pays : United Kingdom

Références

Graf, T. & Stadtfeld, M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 3, 480–483 (2008).
pubmed: 18983963 doi: 10.1016/j.stem.2008.10.007
Hough, S. R., Laslett, A. L., Grimmond, S. B., Kolle, G. & Pera, M. F. A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PloS One 4, e7708 (2009).
pubmed: 19890402 pmcid: 2768791 doi: 10.1371/journal.pone.0007708
Enver, T. et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129–3140 (2005).
pubmed: 16159889 doi: 10.1093/hmg/ddi345
Allison, T. F. et al. Identification and single-cell functional characterization of an endodermally biased pluripotent substate in human embryonic stem cells. Stem Cell Rep. 10, 1895–1907 (2018).
doi: 10.1016/j.stemcr.2018.04.015
Hough Shelley, R. et al. Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells. Stem Cell Rep. 2, 881–895 (2014).
doi: 10.1016/j.stemcr.2014.04.014
Gokhale, P. J. et al. Culture adaptation alters transcriptional hierarchies among single human embryonic stem cells reflecting altered patterns of differentiation. PloS One 10, e0123467 (2015).
pubmed: 25875838 pmcid: 4397016 doi: 10.1371/journal.pone.0123467
Kuroda, T. et al. SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation. Nat. Commun. 10, 2175 (2019).
pubmed: 31092818 pmcid: 6520385 doi: 10.1038/s41467-019-09511-4
Takashima, Y. et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254–1269 (2014).
pubmed: 25215486 pmcid: 4162745 doi: 10.1016/j.cell.2014.08.029
Theunissen Thorold, W. et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15, 471–487 (2014).
pubmed: 25090446 pmcid: 4184977 doi: 10.1016/j.stem.2014.07.002
Gafni, O. et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282–286 (2013).
pubmed: 24172903 doi: 10.1038/nature12745 pmcid: 24172903
Davis, R. P. et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 111, 1876–1884 (2008).
pubmed: 18032708 doi: 10.1182/blood-2007-06-093609 pmcid: 18032708
Loh, K. M. et al. Mapping the pairwise choices leading from pluripotency to human bone, heart, and other mesoderm cell types. Cell 166, 451–467 (2016).
pubmed: 27419872 pmcid: 5474394 doi: 10.1016/j.cell.2016.06.011
Loh, K. M. et al. Efficient endoderm induction from human pluripotent stem cells by logically directing signals controlling lineage bifurcations. Cell Stem Cell 14, 237–252 (2014).
pubmed: 24412311 pmcid: 4045507 doi: 10.1016/j.stem.2013.12.007
Jackson, S. A., Schiesser, J., Stanley, E. G. & Elefanty, A. G. Differentiating embryonic stem cells pass through ‘temporal windows’ that mark responsiveness to exogenous and paracrine mesendoderm inducing signals. PloS One 5, e10706 (2010).
pubmed: 20502661 pmcid: 2873409 doi: 10.1371/journal.pone.0010706
Kempf, H. et al. Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells. Nat. Commun. 7, 13602 (2016).
pubmed: 27934856 pmcid: 5155150 doi: 10.1038/ncomms13602
Draper, J. S., Pigott, C., Thomson, J. A. & Andrews, P. W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249–258 (2002).
pubmed: 12033729 pmcid: 1570685 doi: 10.1046/j.1469-7580.2002.00030.x
Andrews, P. W., Goodfellow, P. N., Shevinsky, L. H., Bronson, D. L. & Knowles, B. B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer 29, 523–531 (1982).
pubmed: 7095898 doi: 10.1002/ijc.2910290507
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
pubmed: 24658644 pmcid: 4122333 doi: 10.1038/nbt.2859
Corish, P. & Tyler-Smith, C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng., Des. Selection 12, 1035–1040 (1999).
doi: 10.1093/protein/12.12.1035
Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424–429 (2011).
pubmed: 21478862 pmcid: 3084903 doi: 10.1038/nmeth.1593
Kurek, D. et al. Endogenous WNT signals mediate bmp-induced and spontaneous differentiation of epiblast stem cells and human embryonic stem cells. Stem Cell Rep. 4, 114–128 (2015).
doi: 10.1016/j.stemcr.2014.11.007
Blauwkamp, T. A., Nigam, S., Ardehali, R., Weissman, I. L. & Nusse, R. Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors. Nat. Commun. 3, 1070 (2012).
pubmed: 22990866 pmcid: 3657997 doi: 10.1038/ncomms2064
Garcia-Gonzalo, F. R. & Izpisúa Belmonte, J. C. Albumin-associated lipids regulate human embryonic stem cell self-renewal. PloS One 3, e1384 (2008).
pubmed: 18167543 pmcid: 2148252 doi: 10.1371/journal.pone.0001384
Hackland, J. O. S. et al. Top-down inhibition of bmp signaling enables robust induction of hPSCs into neural crest in fully defined, Xeno-free conditions. Stem Cell Rep. 9, 1043–1052 (2017).
doi: 10.1016/j.stemcr.2017.08.008
Ng, E. S., Davis, R., Stanley, E. G. & Elefanty, A. G. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc. 3, 768 (2008).
pubmed: 18451785 doi: 10.1038/nprot.2008.42 pmcid: 18451785
Bock, C. et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439–452 (2011).
pubmed: 21295703 pmcid: 3063454 doi: 10.1016/j.cell.2010.12.032
Mendjan, S. et al. NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency. Cell Stem Cell 15, 310–325 (2014).
pubmed: 25042702 doi: 10.1016/j.stem.2014.06.006 pmcid: 25042702
Allison, T. F. et al. Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells. Nat. Commun. 9, 1925 (2018).
doi: 10.1038/s41467-018-04011-3
Frith, T. J. et al. Human axial progenitors generate trunk neural crest cells in vitro. eLife 7, e35786 (2018).
pubmed: 30095409 pmcid: 6101942 doi: 10.7554/eLife.35786
ten Berge, D. et al. Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell 3, 508–518 (2008).
pubmed: 18983966 pmcid: 2683270 doi: 10.1016/j.stem.2008.09.013
Desmarais, J. A., Unger, C., Damjanov, I., Meuth, M. & Andrews, P. Apoptosis and failure of checkpoint kinase 1 activation in human induced pluripotent stem cells under replication stress. Stem Cell Res. Ther. 7, 17 (2016).
pubmed: 26810087 pmcid: 4727355 doi: 10.1186/s13287-016-0279-2
Pébay, A. et al. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells 23, 1541–1548 (2005).
pubmed: 16081668 doi: 10.1634/stemcells.2004-0338
Kiss, G. N. et al. Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Mol. Pharmacol. 82, 1162–1173 (2012).
pubmed: 22968304 pmcid: 3502618 doi: 10.1124/mol.112.079699
Bakre, M. M. et al. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. J. Biol. Chem. 282, 31703–31712 (2007).
pubmed: 17711862 doi: 10.1074/jbc.M704287200
Wang, P., Rodriguez Ryan, T., Wang, J., Ghodasara, A. & Kim Seung, K. Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell 8, 335–346 (2011).
pubmed: 21362573 pmcid: 3063711 doi: 10.1016/j.stem.2011.01.017
Kumar, N. et al. Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells. eLife 4, e08413 (2015).
pubmed: 26554899 pmcid: 4631902 doi: 10.7554/eLife.08413
Cheng, X. et al. Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 10, 371–384 (2012).
pubmed: 22482503 pmcid: 3580854 doi: 10.1016/j.stem.2012.02.024
Tsakiridis, A. et al. Distinct Wnt-driven primitive streak-like populations reflect in vivo lineage precursors. Development 141, 1209–1221 (2014).
pubmed: 24595287 pmcid: 3943179 doi: 10.1242/dev.101014
Brons, I. G. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191–195 (2007).
pubmed: 17597762 doi: 10.1038/nature05950
Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196–199 (2007).
pubmed: 17597760 doi: 10.1038/nature05972
Cooper, S. et al. Biochemical properties of a keratan sulphate/chondroitin sulphate proteoglycan expressed in primate pluripotent stem cells. J. Anat. 200, 259–265 (2002).
pubmed: 12033730 pmcid: 1570689 doi: 10.1046/j.1469-7580.2002.00034.x
Stavish, D. & Price, C. J. Culturing of human pluripotent stem cells in a mesoderm biased state. Nat. Protoc. Exch. https://doi.org/10.21203/rs.3.pex-1100/v1 (2020).
doi: 10.21203/rs.3.pex-1100/v1
Kohler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J. Immunol. 174, 2453–2455 (1975).
Wright, A. et al. Mapping the stem cell state: eight novel human embryonic stem and embryonal carcinoma cell antibodies. Int. J. Androl. 34, e175–e187 (2011). discussion e187-178.
pubmed: 21651578 doi: 10.1111/j.1365-2605.2011.01185.x
Shevinsky, L. H., Knowles, B. B., Damjanov, I. & Solter, D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30, 697–705 (1982).
pubmed: 6183004 doi: 10.1016/0092-8674(82)90274-4
Kannagi, R. et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 2, 2355–2361 (1983).
pubmed: 6141938 pmcid: 555457 doi: 10.1002/j.1460-2075.1983.tb01746.x
Adewumi, O. et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25, 803–816 (2007).
pubmed: 17572666 doi: 10.1038/nbt1318
Andrews, P. W., Banting, G., Damjanov, I., Arnaud, D. & Avner, P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3, 347–361 (1984).
pubmed: 6396197 doi: 10.1089/hyb.1984.3.347
Andrews, P. W., Meyer, L. J., Bednarz, K. L. & Harris, H. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 3, 33–39 (1984).
pubmed: 6205984 doi: 10.1089/hyb.1984.3.33
Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
pubmed: 17076895 pmcid: 1794559 doi: 10.1186/gb-2006-7-10-r100
Becton DaC. FlowJo™ Software (Windows) v10.6.) (2019).
Carpenter, L. et al. Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. Blood 117, 4008–4011 (2011).
pubmed: 21343609 doi: 10.1182/blood-2010-08-299941 pmcid: 21343609
Vodyanik, M. A., Bork, J. A., Thomson, J. A. & Slukvin, I. I. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105, 617–626 (2005).
pubmed: 15374881 doi: 10.1182/blood-2004-04-1649 pmcid: 15374881
Andrews S. FASTQC (a quality control tool for high throughput sequence data.). Babraham Institute (2015).
Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).
pubmed: 25751142 pmcid: 25751142 doi: 10.1038/nmeth.3317
Schneider, V. A. et al. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res. 27, 849–864 (2017).
pubmed: 28396521 pmcid: 5411779 doi: 10.1101/gr.213611.116
Hartley, S. W. & Mullikin, J. C. QoRTs: a comprehensive toolset for quality control and data processing of RNA-Seq experiments. BMC Bioinforma. 16, 224 (2015).
doi: 10.1186/s12859-015-0670-5
Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012).
pubmed: 22383036 pmcid: 3334321 doi: 10.1038/nprot.2012.016
Babraham-Bioinformatics. SeqMonk: a tool to visualise and analyse high throughput mapped sequence data.) (2018).
Love, M., Anders, S. & Huber, W. Differential analysis of count data–the DESeq2 package. Genome Biol. 15, 10.1186 (2014).
doi: 10.1186/s13059-014-0550-8
Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305–W311 (2009).
pubmed: 19465376 pmcid: 2703978 doi: 10.1093/nar/gkp427
Supek, F., Bošnjak, M., Škunca, N. & Šmuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PloS One 6, e21800 (2011).
pubmed: 21789182 pmcid: 3138752 doi: 10.1371/journal.pone.0021800
Sturn, A., Quackenbush, J. & Trajanoski, Z. Genesis: cluster analysis of microarray data. Bioinformatics 18, 207–208 (2002).
pubmed: 11836235 doi: 10.1093/bioinformatics/18.1.207 pmcid: 11836235
Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305–W311 (2009).
pubmed: 19465376 pmcid: 2703978 doi: 10.1093/nar/gkp427

Auteurs

Dylan Stavish (D)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. d.stavish@sheffield.ac.uk.

Charlotta Böiers (C)

Stem Cell Laboratory, Department of Cancer Biology, University College London Cancer Institute, 72 Huntley St, London, WC1E 6AG, UK.

Christopher Price (C)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.

Thomas J R Frith (TJR)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.

Jason Halliwell (J)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.

Ingrid Saldaña-Guerrero (I)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.

Jason Wray (J)

Stem Cell Laboratory, Department of Cancer Biology, University College London Cancer Institute, 72 Huntley St, London, WC1E 6AG, UK.

John Brown (J)

Stem Cell Laboratory, Department of Cancer Biology, University College London Cancer Institute, 72 Huntley St, London, WC1E 6AG, UK.

Jonathon Carr (J)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.

Chela James (C)

Stem Cell Laboratory, Department of Cancer Biology, University College London Cancer Institute, 72 Huntley St, London, WC1E 6AG, UK.

Ivana Barbaric (I)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.

Peter W Andrews (PW)

The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. p.w.andrews@sheffield.ac.uk.

Tariq Enver (T)

Stem Cell Laboratory, Department of Cancer Biology, University College London Cancer Institute, 72 Huntley St, London, WC1E 6AG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH